Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling
Abstract Background Sorafenib (SOR) is the first line treatment for advanced hepatocellular carcinoma (HCC), but resistance develops frequently. Tumor-associated macrophages (TAMs) have been reported to affect the progression of HCC. We therefore aimed to study the role of TAMs in promoting SOR resi...
Main Authors: | Hao-Chen Wang, Lin-Ya Haung, Chih-Jung Wang, Ying-Jui Chao, Ya-Chin Hou, Chia-Jui Yen, Yan-Shen Shan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-022-00881-4 |
Similar Items
-
CXCL1-CXCR2 signalling mediates hypertensive retinopathy by inducing macrophage infiltration
by: Shuai Wang, et al.
Published: (2022-10-01) -
The role of CXCR3 and its ligands in cancer
by: Xiaoming Wang, et al.
Published: (2022-11-01) -
Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy
by: Ruth M. Urbantat, et al.
Published: (2021-10-01) -
CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A
by: Valentina La Cognata, et al.
Published: (2023-07-01) -
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
by: Nathan Reynders, et al.
Published: (2019-06-01)